Author

Thomas D Nolin

University of Pittsburgh - Cited by 6,898 - Clinical pharmacology - pharmacokinetics - nephrology - nephropharmacology - renal replacement therapy

Biography

Experienced pharmaceutical scientist with a demonstrated history of working in academia. Skilled in clinical and translational research, clinical pharmacology, quantitative analytical techniques, medical and pharmacy education, and life sciences. Long standing interest in the role of kidney function and the impact of kidney disease on pharmacokinetics, pharmacodynamics, corresponding drug selection and dosing requirements, and drug development practices and regulatory policies related to each. #nephropharmacology
Title
Cited by
Year
MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs
Z Feng, M Chen, Y Xue, T Liang, H Chen, Y Zhou, TD Nolin, RB Smith, ...Briefings in bioinformatics 22 (2), 946-962, 2021202
24
2021
Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup
A Wong, RS Hoffman, SJ Walsh, DM Roberts, S Gosselin, TE Bunchman, ...Clinical Toxicology 59 (5), 361-375, 2021202
23
2021
Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute …
MA Casal, SP Ivy, JH Beumer, TD NolinThe Lancet Oncology (9), 1333-1340, 2021202
22
2021
Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease
CV Jawale, K Ramani, D Li, BM Coleman, RS Oberoi, S Kupul, L Lin, ...Science translational medicine 12 (548), eaay5691, 2020202
19
2020
Opioids for chronic pain management in patients with dialysis-dependent kidney failure
DG Tobin, MB Lockwood, PL Kimmel, LM Dember, ND Eneanya, ...Nature Reviews Nephrology 18 (2), 113-128, 2022202
15
2022
Extracorporeal treatment for chloroquine, hydroxychloroquine, and quinine poisoning: systematic review and recommendations from the EXTRIP Workgroup
I Berling, JD King, G Shepherd, RS Hoffman, B Alhatali, V Lavergne, ...Journal of the American Society of Nephrology: JASN 31 (10), 2475, 2020202
13
2020
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup
J Bouchard, G Shepherd, RS Hoffman, S Gosselin, DM Roberts, Y Li, ...Critical Care 25 (1), 1-25, 2021202
13
2021
Dose optimization in kidney disease: Opportunities for PBPK modeling and simulation
Y Franchetti, TD NolinThe Journal of Clinical Pharmacology 60, S36-S51, 2020202
10
2020
Adverse drug effects in patients with CKD: primum non nocere
MA Perazella, TD NolinClinical Journal of the American Society of Nephrology: CJASN 15 (8), 75, 2020202
10
2020
Extracorporeal treatment for gabapentin and pregabalin poisoning: systematic review and recommendations from the EXTRIP workgroup
J Bouchard, C Yates, DP Calello, S Gosselin, DM Roberts, V Lavergne, ...American Journal of Kidney Diseases 79 (1), 88-4, 2022202
10
2022
Randomized, placebo-controlled trial of rifaximin therapy for lowering gut-derived cardiovascular toxins and inflammation in CKD
C Kimber, S Zhang, C Johnson, RE West III, AJ Prokopienko, JD Mahnken, ...Kidney360 1 (11), 1206, 2020202
9
2020
Association of rosuvastatin use with risk of hematuria and proteinuria
JI Shin, DM Fine, Y Sang, A Surapaneni, SC Dunning, LA Inker, TD Nolin, ...Journal of the American Society of Nephrology 33 (9), 16-1, 2022202
7
2022
Recommendations from the EXTRIP workgroup on extracorporeal treatment for baclofen poisoning
M Ghannoum, I Berling, V Lavergne, DM Roberts, T Galvao, RS Hoffman, ...Kidney International 100 (4), 720-736, 2021202
5
2021
Extracorporeal treatment for methotrexate poisoning: systematic review and recommendations from the EXTRIP Workgroup
M Ghannoum, DM Roberts, DS Goldfarb, J Heldrup, K Anseeuw, ...Clinical Journal of the American Society of Nephrology 17 (4), 602-622, 2022202
5
2022
Mechanistic considerations and pharmacokinetic implications on concomitant drug administration during cytosorb therapy
J Scheier, PJ Nelson, A Schneider, S Colombier, D Kindgen-Milles, ...Critical Care Explorations 4 (), 2022202
5
2022
Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Impact of Chronic Kidney Disease on CYP3A4‐Mediated Metabolism of Saxagliptin
Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Impact of Chronic Kidney Disease on CYP3A‐Mediated Metabolism of SaxagliptinMA Butrovich, W Tang, DW Boulton, TD Nolin, P SharmaThe Journal of Clinical Pharmacology 62 (8), 1018-1029, 2022202
4
2022
Inclusion of participants with CKD and other kidney-related considerations during clinical drug development: landscape analysis of anticancer agents approved from 2015 to 2019
MA Butrovich, AC Reaves, J Heyward, TJ Moore, GC Alexander, LA Inker, ...The Clinical Journal of the American Society of Nephrology 18 (), 55-6, 2023202
4
2023
Education standards for pharmacists providing comprehensive medication management in outpatient nephrology settings
JQ Hudson, R Maxson, EF Barreto, K Cho, AJ Condon, E Goswami, ...Kidney Medicine 4 (8), 100508, 2022202
3
2022
New Vancomycin Dosing Guidelines for Hemodialysis Patients: Rationale, Caveats, and Limitations
SJ Lewis, TD NolinKidney360 (8), 1313, 010
2
2021
Extracorporeal treatments for isoniazid poisoning: Systematic review and recommendations from the EXTRIP workgroup
JB Mowry, G Shepherd, RS Hoffman, V Lavergne, S Gosselin, TD Nolin, ...Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41 (5 …, 010
2
2021

Referred From: https://scholar.google.com/citations?user=kh8OTmAAAAAJ&hl=en

Cited by
Citations 6898
h-index 48
i10-index 90
Recommended Journals
Open Access Journals